Neo Gen Screening is a leader in the fieild of newborn screening. This news and information page presents the latest developments at Neo Gen Screening in terms of technology, partner laboratories, general business information and the latest newborn screening statistics. We will also provide links to articles about Neo Gen Screening and the technology used in our laboratory as well as the pioneering research performed by our expert staff of investigators and collaborators.  Please check this page often to receive the latest information from Neo Gen Screening.

American Academy of Forensic Science Annual Meeting (February 23, 2000)

Neo Gen Screening presented autopsy screening services to forensic pathologists at the annual convention for forensic scientist.  Neo Gen Screening is the largest provider of postmortem blood sample analysis and screening for metabolic causes of Sudden Infant Death Syndrome (SIDS) in the United States. 

(February11, 2000)

CBS Evening news with Dan Rather on the Friday evening news (2/11/2000) reported on newborn screening in the US and why some parents get comprehensive screening and others do not. 

(February, 2000)

US News and World report pubished an article pertaining to expanded newborn screening entitled "Little Used Test Can Prevent Real Heartache" by Susan Brink in the January 17th issue.  Neo Gen Screening offers supplemental screening to parents, hospitals and states. Early testing using state-of-the-art technology prevents the "Real Heartache" that is described in the article.

Supplemental Screening in Pennsylvania  (August 1, 1999)

Link to a story in the health section of the describing newborn screening in Pennsylvania.  Neo Gen Screening offers supplemental screening services to nearly 70% of all hospitals in Pennsylvania.  Does your hospital subscribe to our state-of-the-art screening program?  Call us at Neo Gen Screening for more information.

ISNS Meeting in Sweden (July 1, 1999)

Neo Gen Screening and Cambridge Isotopes jointly presented products and services at the International Society of Neontal Screening in Stockholm, Sweden. 

Newborn Screening in Turkey (February 15, 1999)

Neo Gen Screening and Yenidogan Turkiye  have entered into a partnership to provide state-of-the-art newborn screening services in Turkey. In the agreement, Yenidogan Turkiye becomes the exclusive representative of Neo Gen Screening in Turkey for performing newborn screening services and diagnosis of inborn errors of metabolism.

Clinical Mass Spectrometry Conference (January 23-26, 1999)

Dr. Don Chace, the director of the Mass Spectrometry laboratory, co-organized the 11th Sanibel Conference on Mass Spectometry. The conference sponsored by the American Society of Mass Spectrometry focused on new and emerging applications and technologies in mass spectrometry that are impacting the clinical diagnosis of diseases states.  The meeting was well attended and by all measures a success.

Newborn Screening in Brazil (January 15, 1999)

Neo Gen Screening and Fleury Laboratories have entered into a partnership to provide state-of-the-art newborn screening services in Brazil. In the agreement, Fleury Laboratories becomes the exclusive representative of Neo Gen Screening in Brazil for performing newborn screening services and diagnosis of inborn errors of metabolism.

  A New Era In Newborn Screening (December 2, 1998).

In the December Issue of Clinical Chemistry, Dr. Don Chace and coauthors from the California Department of Health Services and Duke University Medical Center, report on the use of tandem mass spectrometry in providing more accurate early testing of newborns for PKUz. The manuscript is accompanied by an editorial written by Dr. Harvey Levy of Boston Children's Hospital.

"At First Cry" was a related story from HealthScout authored by Michael Easterbrook. In this article both Dr. Donald Chace (Neo Gen Screening) and Dr. Harvey Levy (Boston Children's Hospital were interviewed.

Newborn Screening in Mexico (Septermber 1, 1998)

Neo Gen Screening and CEMEG (Centro de Estudios Metabólicos y Genéticos) have entered into a partnership to provide state-of-the-art newborn screening services in Mexico. In the agreement, CEMEG becomes the exclusive representative of Neo Gen Screening in Mexico for performing newborn screening services and diagnosis of inborn errors of metabolism.

Pittsburgh 100 (August 25, 1998)

Neo Gen Screening was honored on August 24, 1998 for becoming one of Pittsburgh's top 100 fastest growing companies. We were ranked 51st. Congratulations to the staff at Neo Gen Screening for its excellent work.

[Home] [Info] [News] [Sales] [R&D] [Staff] [Results]

© 2000 Neo Gen Screening. All rights reserved.